Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma - PubMed (original) (raw)
. 2007 Aug;48(8):1348-56.
doi: 10.2967/jnumed.107.041673. Epub 2007 Jul 13.
Affiliations
- PMID: 17631542
- DOI: 10.2967/jnumed.107.041673
Free article
Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma
Tien Q Pham et al. J Nucl Med. 2007 Aug.
Free article
Abstract
Radiopharmaceuticals that can target the random metastatic dissemination of melanoma tumors may present opportunities for imaging and staging the disease as well as potential radiotherapeutic applications. A novel molecule, 2-(2-(4-(4-(123)I-iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione (MEL037), was synthesized, labeled with 123I, and evaluated for application in melanoma tumor scintigraphy and radiotherapy.
Methods: The tumor imaging potential of 123I-MEL037 was studied in vivo in C57BL/6J female mice bearing the B16F0 murine melanoma tumor and in BALB/c nude mice bearing the A375 human amelanotic melanoma tumor by biodistribution, competition studies, and SPECT.
Results: 123I-MEL037 exhibited high and rapid uptake in the B16F0 melanoma tumor at 1 h (13 %ID/g [percentage injected dose per gram]), increasing with time to reach 25 %ID/g at 6 h. A significant uptake was also observed in the eyes (2 %ID, at 3-6 h after injection) of black mice. No uptake was observed in the tumor or in the eyes of nude mice bearing the A375 tumor. Because of high uptake and long retention in the tumor and rapid body clearance, the mean contrast ratios (MCR) of 123I-MEL037 were 30 and 60, at 24 and 48 h after injection, respectively. At 24 h after injection of mice bearing the B16 melanoma, SPECT indicated that the radioactivity was located predominately in the tumor followed by the eyes, whereas no specific localization of the radioactivity was noted in mice bearing the A375 human amelanotic tumor. In competition experiments, uptake of 123I-MEL037 in brain, lung, heart, and kidney--organs known to contain sigma-receptors--was not significantly different in haloperidol-treated animals compared with control animals. Therefore, reduction of uptake in tumor and eyes of the pigmented mice bearing the B16F0 tumor suggested that the mechanism of tumor uptake was likely due to an interaction with melanin.
Conclusion: These findings suggested that 123I-MEL037, which displays a rapid and very high tumor uptake, appeared to be a promising imaging agent for detection of most melanoma tumors with the potential for development as a therapeutic agent in melanoma tumor proliferation.
Similar articles
- Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
Liu X, Pham TQ, Berghofer P, Chapman J, Greguric I, Mitchell P, Mattner F, Loc'h C, Katsifis A. Liu X, et al. Nucl Med Biol. 2008 Oct;35(7):769-81. doi: 10.1016/j.nucmedbio.2008.05.011. Nucl Med Biol. 2008. PMID: 18848662 - Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
Pham TQ, Greguric I, Liu X, Berghofer P, Ballantyne P, Chapman J, Mattner F, Dikic B, Jackson T, Loc'h C, Katsifis A. Pham TQ, et al. J Med Chem. 2007 Jul 26;50(15):3561-72. doi: 10.1021/jm0701627. Epub 2007 Jun 28. J Med Chem. 2007. PMID: 17602544 - Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC, Chang CH, Shen CC, Chen CL, Liu RS, Lin MH, Wang HE. Chang CC, et al. Bioorg Med Chem. 2015 May 1;23(9):2261-9. doi: 10.1016/j.bmc.2015.02.017. Epub 2015 Mar 4. Bioorg Med Chem. 2015. PMID: 25800432 - 2-(2-(4-(4-[123I]Iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione.
Cheng KT, Katsifis A. Cheng KT, et al. 2007 Jul 31 [updated 2008 Jan 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Jul 31 [updated 2008 Jan 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641514 Free Books & Documents. Review. - _N_-(2-(Diethylamino)ethyl)-5-[123I]iodonicotinamide.
Leung K. Leung K. 2009 Oct 7 [updated 2010 Mar 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2009 Oct 7 [updated 2010 Mar 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641349 Free Books & Documents. Review.
Cited by
- Anti-tumor activity of splice-switching oligonucleotides.
Bauman JA, Li SD, Yang A, Huang L, Kole R. Bauman JA, et al. Nucleic Acids Res. 2010 Dec;38(22):8348-56. doi: 10.1093/nar/gkq731. Epub 2010 Aug 18. Nucleic Acids Res. 2010. PMID: 20719743 Free PMC article. - Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation.
Cristancho Ortiz CJ, de Freitas Silva M, Pruccoli L, Fonseca Nadur N, de Azevedo LL, Kümmerle AE, Guedes IA, Dardenne LE, Leomil Coelho LF, Guimarães MJ, da Silva FMR, Castro N, Gontijo VS, Rojas VCT, de Oliveira MK, Vilela FC, Giusti-Paiva A, Barbosa G, Lima LM, Pinheiro GB, Veras LG, Mortari MR, Tarozzi A, Viegas C Jr. Cristancho Ortiz CJ, et al. RSC Med Chem. 2022 Mar 17;13(5):568-584. doi: 10.1039/d1md00374g. eCollection 2022 May 25. RSC Med Chem. 2022. PMID: 35694691 Free PMC article. - An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.
Chono S, Li SD, Conwell CC, Huang L. Chono S, et al. J Control Release. 2008 Oct 6;131(1):64-9. doi: 10.1016/j.jconrel.2008.07.006. Epub 2008 Jul 13. J Control Release. 2008. PMID: 18674578 Free PMC article. - Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.
Li SD, Chono S, Huang L. Li SD, et al. Mol Ther. 2008 May;16(5):942-6. doi: 10.1038/mt.2008.51. Epub 2008 Mar 18. Mol Ther. 2008. PMID: 18388916 Free PMC article. - Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Chen CC, Chen YY, Lo YH, Lin MH, Chang CH, Chen CL, Wang HE, Wu CY. Chen CC, et al. Int J Mol Sci. 2020 Sep 9;21(18):6597. doi: 10.3390/ijms21186597. Int J Mol Sci. 2020. PMID: 32916962 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical